This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Sally Ward, PhD
Professor at University of Southampton and Texas A&M University Health Science Center

Profile

Sally Ward completed her Ph.D. research in the Department of Biochemistry, Cambridge University, Cambridge, U.K. in 1985 under the mentorship of Professor David Ellar. From 1985-1988 she was a Research Fellow at Gonville and Caius College whilst working at the Department of Biochemistry, Cambridge University. From 1988 to 1990, she held the Stanley Elmore Senior Research Fellowship at Sidney Sussex College and carried out research in Sir Greg Winter’s laboratory at the MRC Laboratory of Molecular Biology in Cambridge.

In 1990 she joined the University of Texas Southwestern Medical Center, Dallas, as an Assistant Professor. From 2002-2014, she was a Professor in the Department of Immunology at the same institution and in 2004 was appointed to the Paul and Betty Meek-FINA Professorship in Molecular Immunology. Since 2014, she has been a Professor at Texas A&M University Health Science Center. She has recently been appointed as the Director of Translational Immunology and Professor of Molecular Immunology at the Centre for Cancer Immunology at the University of Southampton in England. Her research involves the use of protein engineering to modulate antibody behavior at the subcellular and whole body levels, with the goal of developing therapeutics to treat cancer and autoimmunity. She is a member of the Board of Distinguished Advisors in the Antibody Society and serves on the editorial boards of mAbs and Protein Engineering, Design and Selection. In 2010, she was the founding co-organizer of the Antibody Biology and Engineering Gordon Research Conference.

Agenda Sessions

  • LIVE Moderated Panel Discussion and Q&A Including Audience Interaction with Speakers from On-Demand SESSION #6: MODIFYING FC INTERACTIONS TO ENHANCE ANTIBODY THERAPIES - To prepare for this discussion/Q&A, attendees should view the presentations from Session #6 in the Watch On-Demand Sessions Tab prior to this session

    11:15
  • LIVE Moderated Panel Discussion and Q&A Including Audience Interaction with Speakers from On-Demand SESSION #2: THE “NUTS AND BOLTS” OF ANTIBODIES - To prepare for this discussion/Q&A, attendees should view the presentations from Session #2 in the Watch On-Demand Sessions Tab prior to this session

    14:30
  • SESSION CHAIR: Mark Your Calendar for Wednesday, August 26, 11:15-12:00 for the Live Speaker Q&A/Panel Discussion with the Speakers in this Session - Check the "Watch Live" Session Tab for Details. We Recommend That You Watch These On-Demand Presentations Prior to the Live Q&A/Panel

    00:00
  • Targeting Subcellular Trafficking Behavior to Generate Therapeutic Antibodies

    02:05